The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oxaliplatin API Market Research Report 2025
Synopsis
The appearance is white or similar white powder, has the anti-tumor, the inhibition cell mitosis function. The molecular formula is C16H16ClN3O3S, and CAS number is 61825-94-3.
The global Oxaliplatin API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oxaliplatin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxaliplatin API.
Report Scope
The Oxaliplatin API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oxaliplatin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oxaliplatin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Scion Pharm Taiwan
Acebright
Sai Phytoceuticals
Nischem International
Polymed Therapeutics
Fresenius Kabi Oncology
Tapi Teva
Heraeus
Shilpa Medicare Limited
Vinkem Labs
Chem Genix
Cipla
Qilu Pharmaceutial
VUAB Pharma
Berr Chemical
Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %
Segment by Application
Oxaliplatin Injection
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oxaliplatin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Oxaliplatin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Oxaliplatin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
The appearance is white or similar white powder, has the anti-tumor, the inhibition cell mitosis function. The molecular formula is C16H16ClN3O3S, and CAS number is 61825-94-3.
The global Oxaliplatin API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oxaliplatin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxaliplatin API.
Report Scope
The Oxaliplatin API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oxaliplatin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oxaliplatin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Scion Pharm Taiwan
Acebright
Sai Phytoceuticals
Nischem International
Polymed Therapeutics
Fresenius Kabi Oncology
Tapi Teva
Heraeus
Shilpa Medicare Limited
Vinkem Labs
Chem Genix
Cipla
Qilu Pharmaceutial
VUAB Pharma
Berr Chemical
Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %
Segment by Application
Oxaliplatin Injection
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oxaliplatin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Oxaliplatin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Oxaliplatin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Oxaliplatin API Market Overview
1.1 Product Definition
1.2 Oxaliplatin API Segment by Type
1.2.1 Global Oxaliplatin API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity ≥ 98 %
1.2.3 Purity ≥ 99 %
1.3 Oxaliplatin API Segment by Application
1.3.1 Global Oxaliplatin API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Oxaliplatin Injection
1.3.3 Other
1.4 Global Market Growth Prospects
1.4.1 Global Oxaliplatin API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Oxaliplatin API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Oxaliplatin API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Oxaliplatin API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Oxaliplatin API Production Market Share by Manufacturers (2019-2024)
2.2 Global Oxaliplatin API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Oxaliplatin API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Oxaliplatin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Oxaliplatin API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Oxaliplatin API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Oxaliplatin API, Product Offered and Application
2.8 Global Key Manufacturers of Oxaliplatin API, Date of Enter into This Industry
2.9 Oxaliplatin API Market Competitive Situation and Trends
2.9.1 Oxaliplatin API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Oxaliplatin API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Oxaliplatin API Production by Region
3.1 Global Oxaliplatin API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Oxaliplatin API Production Value by Region (2019-2030)
3.2.1 Global Oxaliplatin API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Oxaliplatin API by Region (2025-2030)
3.3 Global Oxaliplatin API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Oxaliplatin API Production by Region (2019-2030)
3.4.1 Global Oxaliplatin API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Oxaliplatin API by Region (2025-2030)
3.5 Global Oxaliplatin API Market Price Analysis by Region (2019-2024)
3.6 Global Oxaliplatin API Production and Value, Year-over-Year Growth
3.6.1 North America Oxaliplatin API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Oxaliplatin API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Oxaliplatin API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Oxaliplatin API Production Value Estimates and Forecasts (2019-2030)
4 Oxaliplatin API Consumption by Region
4.1 Global Oxaliplatin API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Oxaliplatin API Consumption by Region (2019-2030)
4.2.1 Global Oxaliplatin API Consumption by Region (2019-2024)
4.2.2 Global Oxaliplatin API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Oxaliplatin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Oxaliplatin API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Oxaliplatin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Oxaliplatin API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Oxaliplatin API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Oxaliplatin API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Oxaliplatin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Oxaliplatin API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Oxaliplatin API Production by Type (2019-2030)
5.1.1 Global Oxaliplatin API Production by Type (2019-2024)
5.1.2 Global Oxaliplatin API Production by Type (2025-2030)
5.1.3 Global Oxaliplatin API Production Market Share by Type (2019-2030)
5.2 Global Oxaliplatin API Production Value by Type (2019-2030)
5.2.1 Global Oxaliplatin API Production Value by Type (2019-2024)
5.2.2 Global Oxaliplatin API Production Value by Type (2025-2030)
5.2.3 Global Oxaliplatin API Production Value Market Share by Type (2019-2030)
5.3 Global Oxaliplatin API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Oxaliplatin API Production by Application (2019-2030)
6.1.1 Global Oxaliplatin API Production by Application (2019-2024)
6.1.2 Global Oxaliplatin API Production by Application (2025-2030)
6.1.3 Global Oxaliplatin API Production Market Share by Application (2019-2030)
6.2 Global Oxaliplatin API Production Value by Application (2019-2030)
6.2.1 Global Oxaliplatin API Production Value by Application (2019-2024)
6.2.2 Global Oxaliplatin API Production Value by Application (2025-2030)
6.2.3 Global Oxaliplatin API Production Value Market Share by Application (2019-2030)
6.3 Global Oxaliplatin API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Scion Pharm Taiwan
7.1.1 Scion Pharm Taiwan Oxaliplatin API Corporation Information
7.1.2 Scion Pharm Taiwan Oxaliplatin API Product Portfolio
7.1.3 Scion Pharm Taiwan Oxaliplatin API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Scion Pharm Taiwan Main Business and Markets Served
7.1.5 Scion Pharm Taiwan Recent Developments/Updates
7.2 Acebright
7.2.1 Acebright Oxaliplatin API Corporation Information
7.2.2 Acebright Oxaliplatin API Product Portfolio
7.2.3 Acebright Oxaliplatin API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Acebright Main Business and Markets Served
7.2.5 Acebright Recent Developments/Updates
7.3 Sai Phytoceuticals
7.3.1 Sai Phytoceuticals Oxaliplatin API Corporation Information
7.3.2 Sai Phytoceuticals Oxaliplatin API Product Portfolio
7.3.3 Sai Phytoceuticals Oxaliplatin API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Sai Phytoceuticals Main Business and Markets Served
7.3.5 Sai Phytoceuticals Recent Developments/Updates
7.4 Nischem International
7.4.1 Nischem International Oxaliplatin API Corporation Information
7.4.2 Nischem International Oxaliplatin API Product Portfolio
7.4.3 Nischem International Oxaliplatin API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Nischem International Main Business and Markets Served
7.4.5 Nischem International Recent Developments/Updates
7.5 Polymed Therapeutics
7.5.1 Polymed Therapeutics Oxaliplatin API Corporation Information
7.5.2 Polymed Therapeutics Oxaliplatin API Product Portfolio
7.5.3 Polymed Therapeutics Oxaliplatin API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Polymed Therapeutics Main Business and Markets Served
7.5.5 Polymed Therapeutics Recent Developments/Updates
7.6 Fresenius Kabi Oncology
7.6.1 Fresenius Kabi Oncology Oxaliplatin API Corporation Information
7.6.2 Fresenius Kabi Oncology Oxaliplatin API Product Portfolio
7.6.3 Fresenius Kabi Oncology Oxaliplatin API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Fresenius Kabi Oncology Main Business and Markets Served
7.6.5 Fresenius Kabi Oncology Recent Developments/Updates
7.7 Tapi Teva
7.7.1 Tapi Teva Oxaliplatin API Corporation Information
7.7.2 Tapi Teva Oxaliplatin API Product Portfolio
7.7.3 Tapi Teva Oxaliplatin API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Tapi Teva Main Business and Markets Served
7.7.5 Tapi Teva Recent Developments/Updates
7.8 Heraeus
7.8.1 Heraeus Oxaliplatin API Corporation Information
7.8.2 Heraeus Oxaliplatin API Product Portfolio
7.8.3 Heraeus Oxaliplatin API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Heraeus Main Business and Markets Served
7.7.5 Heraeus Recent Developments/Updates
7.9 Shilpa Medicare Limited
7.9.1 Shilpa Medicare Limited Oxaliplatin API Corporation Information
7.9.2 Shilpa Medicare Limited Oxaliplatin API Product Portfolio
7.9.3 Shilpa Medicare Limited Oxaliplatin API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Shilpa Medicare Limited Main Business and Markets Served
7.9.5 Shilpa Medicare Limited Recent Developments/Updates
7.10 Vinkem Labs
7.10.1 Vinkem Labs Oxaliplatin API Corporation Information
7.10.2 Vinkem Labs Oxaliplatin API Product Portfolio
7.10.3 Vinkem Labs Oxaliplatin API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Vinkem Labs Main Business and Markets Served
7.10.5 Vinkem Labs Recent Developments/Updates
7.11 Chem Genix
7.11.1 Chem Genix Oxaliplatin API Corporation Information
7.11.2 Chem Genix Oxaliplatin API Product Portfolio
7.11.3 Chem Genix Oxaliplatin API Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Chem Genix Main Business and Markets Served
7.11.5 Chem Genix Recent Developments/Updates
7.12 Cipla
7.12.1 Cipla Oxaliplatin API Corporation Information
7.12.2 Cipla Oxaliplatin API Product Portfolio
7.12.3 Cipla Oxaliplatin API Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Cipla Main Business and Markets Served
7.12.5 Cipla Recent Developments/Updates
7.13 Qilu Pharmaceutial
7.13.1 Qilu Pharmaceutial Oxaliplatin API Corporation Information
7.13.2 Qilu Pharmaceutial Oxaliplatin API Product Portfolio
7.13.3 Qilu Pharmaceutial Oxaliplatin API Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Qilu Pharmaceutial Main Business and Markets Served
7.13.5 Qilu Pharmaceutial Recent Developments/Updates
7.14 VUAB Pharma
7.14.1 VUAB Pharma Oxaliplatin API Corporation Information
7.14.2 VUAB Pharma Oxaliplatin API Product Portfolio
7.14.3 VUAB Pharma Oxaliplatin API Production, Value, Price and Gross Margin (2019-2024)
7.14.4 VUAB Pharma Main Business and Markets Served
7.14.5 VUAB Pharma Recent Developments/Updates
7.15 Berr Chemical
7.15.1 Berr Chemical Oxaliplatin API Corporation Information
7.15.2 Berr Chemical Oxaliplatin API Product Portfolio
7.15.3 Berr Chemical Oxaliplatin API Production, Value, Price and Gross Margin (2019-2024)
7.15.4 Berr Chemical Main Business and Markets Served
7.15.5 Berr Chemical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Oxaliplatin API Industry Chain Analysis
8.2 Oxaliplatin API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Oxaliplatin API Production Mode & Process
8.4 Oxaliplatin API Sales and Marketing
8.4.1 Oxaliplatin API Sales Channels
8.4.2 Oxaliplatin API Distributors
8.5 Oxaliplatin API Customers
9 Oxaliplatin API Market Dynamics
9.1 Oxaliplatin API Industry Trends
9.2 Oxaliplatin API Market Drivers
9.3 Oxaliplatin API Market Challenges
9.4 Oxaliplatin API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
